Related Experiment Video
Updated: Aug 17, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Anticoagulation of the Elderly Patient
1Hamilton Civic Hospitals Research Centre and McMaster University, Hamilton, Ontario, Canada.
The American Journal of Geriatric Cardiology
|June 21, 2001
Summary
Elderly patients on long-term oral anticoagulant therapy face a higher risk of bleeding complications. This review explores reasons for this increased hemorrhage risk and strategies to mitigate it in older adults.
Area of Science:
- Geriatrics
- Pharmacology
- Vascular Medicine
Background:
- Oral anticoagulant therapy is crucial for managing thromboembolic and vascular disorders.
- These conditions and their treatments are more common in the elderly population.
- Hemorrhage is a significant complication of anticoagulant use.
Purpose of the Study:
- To examine the heightened risk of major hemorrhage in elderly patients undergoing long-term oral anticoagulant therapy.
- To elucidate the underlying reasons for this increased bleeding risk in older individuals.
- To discuss clinical implications and propose strategies for reducing hemorrhage frequency in this demographic.
Main Methods:
- Literature review and synthesis of existing studies on anticoagulant therapy in the elderly.
- Analysis of factors contributing to increased bleeding risk in older patients.
- Discussion of clinical outcomes and preventative measures.
Main Results:
- Conflicting results exist regarding the precise magnitude of risk, but evidence suggests an increased susceptibility to major hemorrhage in the elderly.
- Identifies specific physiological and clinical factors contributing to this heightened risk.
- Highlights the clinical significance of anticoagulant-related bleeding in older populations.
Conclusions:
- Older patients may be at a greater risk for major hemorrhage during oral anticoagulant therapy.
- Understanding these risks is essential for optimizing treatment and patient safety.
- Proactive strategies are needed to reduce the incidence of major hemorrhage in elderly patients receiving anticoagulants.
More Related Videos
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...